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Epithelial cells lining the proximal tubule of the kidney
reabsorb and metabolize most of the filtered low-
molecular-weight proteins through receptor-mediated
endocytosis and lysosomal processing. Congenital and
acquired dysfunctions of the proximal tubule are
consistently reflected by the inappropriate loss of solutes
including low-molecular-weight proteins in the urine. The
zebrafish pronephros shares individual functional
segments with the human nephron, including lrp2a/
megalin-dependent endocytic transport processes of the
proximal tubule. Although the zebrafish has been used as a
model organism for toxicological studies and drug
discovery, there is no available assay that allows large-scale
assessment of proximal tubule function in larval or adult
stages. Here we establish a transgenic Tg(lfabp::1/2vdbp-
mCherry) zebrafish line expressing in the liver the N-
terminal region of vitamin D-binding protein coupled to
the acid-insensitive, red monomeric fluorescent protein
mCherry (1/2vdbp-mCherry). This low-molecular-weight
protein construct is secreted into the bloodstream, filtered
through the glomerulus, reabsorbed by receptor-mediated
endocytosis and processed in the lysosomes of proximal
tubule cells of the fish. Thus, our proof-of-concept studies
using zebrafish larvae knockout for lrp2a and clcn7 or
exposed to known nephrotoxins (gentamicin and cisplatin)
demonstrate that this transgenic line is useful to monitor
low-molecular-weight proteinuria and lysosomal
processing. This represents a powerful new model
organism for drug screening and studies of nephrotoxicity.
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j.kint.2019.11.016
KEYWORDS: endocytosis; lysosome; model organism; proximal tubule; renal
Fanconi syndrome
Copyright ª 2019, International Society of Nephrology. Published by
Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
T
he proximal tubule (PT) of the kidney plays a key role
in homeostasis, via the reabsorption and processing of
a large amount of filtered solutes through specialized
transport systems. In physiological conditions, the epithelial
cells lining the PT reabsorb the filtered low-molecular-weight
(LMW) proteins (MWup to that of albumin,w69 kilodalton
[kDa]), including hormones, vitamins and their binding
proteins, enzymes, immunoglobulin light chains, as well as
drugs and toxins via apical receptor-mediated endocytosis
and lysosomal processing. This pathway is particularly devel-
oped in PT cells, ensuring that human urine is virtually
devoid of ultrafiltered plasma proteins under physiological
conditions.1 Congenital or acquired disorders targeting the
endolysosomal system in PT cells cause an inappropriate
loss of LMW proteins and solutes in the urine, which can
culminate in renal Fanconi syndrome leading to severe clin-
ical manifestations, including renal failure, growth retarda-
tion, rickets, and kidney stones.2,3 Detecting specific LMW
proteinuria is the most consistent and sensitive indicator of
PT dysfunction of genetic and toxic origin.4,5
The overall conservation of nephron segment patterning
has established the zebrafish as a prominent model organism
for kidney diseases and drug discovery.6,7 In particular, the
proximal convoluted tubule segment of the zebrafish pro-
nephros is remarkably similar to the human nephron.8 The
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Translational Statement
A series of congenital or acquired disorders can cause
proximal tubule dysfunction, reflected by the inappro-
priate loss of solutes, including low-molecular-weight
proteins in the urine. The zebrafish pronephros shares
individual functional segments with the human
nephron, and it has been used as a model organism for
toxicologic studies and drug discovery. We established a
transgenic zebrafish line expressing a 50-kilodalton red
fluorescent reporter protein (1/2vdbp-mCherry), which
allows large-scale assessment of proximal tubule func-
tion in larval or adult stages. Proof-of-concept studies
demonstrate that this transgenic line is useful for
monitoring the low-molecular-weight proteinuria and
lysosomal processing and is thus a powerful new model
organism for drug screening and nephrotoxicity studies.
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proximal convoluted tubule cells show the typical character-
istics of reabsorbing epithelia (brush border, infoldings of
basolateral plasma membrane, abundant mitochondrial
network, formation of tight junctions), express the endocytic
receptors megalin and cubilin, and possess lrp2a/megalin-
dependent endocytic transport activity.9 Zebrafish models of
drug toxicity,10 or genetic disorders targeting the
endosomal–lysosomal pathway, including Donnai-Barrow
syndrome,11 Lowe syndrome,12,13 and cystinosis,14,15
support the use of zebrafish pronephros to investigate the
endolysosomal system in PT cells.
In general, evaluation of toxicity of chemical compounds
in zebrafish relies on visual examination of larval features
(e.g., body size, shape) and morphology of internal or-
gans,16,17 whereas assessment of PT function relies on visu-
alization of the uptake of injected LMW fluorescent
tracers.9,12 However, these assays are either indirect or limited
by technical concerns (e.g., injection, visualization), can be
difficult to quantify, and can be affected by quenching of
fluorescence within acidic endolysosomal vesicles. As they are
labor-intensive, the injection methods do not allow large-
scale assessment of PT dysfunction in larvae or adult zebra-
fish models. Detecting biomarkers in fish urine is difficult, as
such markers are diluted in the pool,18 and filtration/pro-
cessing of endogenous LMW proteins has not been charac-
terized. We hypothesized that these difficulties could be
overcome with a transgenic zebrafish reporter line expressing
a fluorescent, LMW protein amenable to PT endocytosis and
processing. The vitamin D binding protein (VDBP) is
secreted from liver hepatocytes into the bloodstream, filtered
through the glomerulus, and entirely reabsorbed by PT cells
via megalin-mediated endocytosis.19 Increased urinary levels
of VDBP are used to detect a variety of acute and chronic
disorders affecting the kidney PT.20–24
Based on the availability of specific tools for gene editing
and kidney PT investigation, we have generated and charac-
terized transgenic zebrafish vdbp reporter lines for analysis of
LMW proteinuria in congenital and acquired PT disorders. By
combining genetic models and exposure to known toxins, we
provide proof-of-concept evidence that substantiates the
value of such zebrafish lines for large-scale screens of kidney
PT function.
RESULTS
Assessment of the endolysosomal pathways in zebrafish
models
In order to explore the endolysosomal pathways in zebrafish
PT, we generated mutant knockout lines for lrp2a (coding for
megalin) and clcn7 (coding for the lysosomal channel ClC-7)
using transcription activator–like effector nucleases (TALEN)
technology. Two mutant lines were identified—lrp2adel8/del8
and clcn7del4/del4—with small deletions in target exons
resulting in premature stop codons and truncated proteins
(Supplementary Figures S1 and S2). The homozygous mutant
lines displayed normal Mendelian ratios at birth, no devel-
opmental defects during the larval stage, normal fertility, and
no visible anomalies, except for the observation of an
enlarged eye globe in lrp2a homozygous adult mutant fish
(Supplementary Figure S1).
In vivo endocytic assays were performed after i.v. injection
of 18.4-kDa b-lactoglobulin-Cy5 (to measure receptor-
mediated endocytosis) and 10-kDa dextran-Alexa Fluor 647
(to measure fluid-phase endocytosis) in 56-hour post-
fertilization (hpf) zebrafish larvae with green fluorescent
pronephric tubules [transgenic Tg(cdh17::GFP); Figure 1a–c].
Injected b-lactoglobulin-Cy5 was taken up within 20 minutes
by pronephric PT cells of lrp2aþ/þ larvae, whereas virtually
no fluorescent signal was observed in lrp2adel8/del8 larvae
(lrp2aþ/þ: 11.3  0.4 vs. lrp2adel8/del8: 0.3  0.1, P < 0.001;
Figure 1a). A similar defect in the uptake of 10-kDa dextran
by pronephric PT cells was observed at 60 minutes in
lrp2adel8/del8 larvae (lrp2aþ/þ: 3.9  0.4 vs. lrp2adel8/del8: 0.5 
0.1, P < 0.001; Figure 1b). Ultrastructure analysis of PT cells
by transmission electron microscopy showed a significant
reduction in the number of endocytic vesicles in lrp2a-defi-
cient larvae, compared to lrp2aþ/þ PT cells (lrp2aþ/þ: 40.5 
4.6 vs. lrp2adel8/del8: 19.6  3.4, P < 0.001; Figure 1c).
Morphologic analysis using the endosome reporter line
Tg(PiT1::GFP-rab5aa) revealed green fluorescent protein
(GFP) fluorescence enriched at the apical side of PT cells in
lrp2aþ/þ larvae, which was absent in lrp2adel8/del8 larvae
(lrp2aþ/þ: 18.6  3.7 vs. lrp2adel8/del8: 9.6  1.0, P < 0.05;
Figure 1d).
The lysosomal processing was analyzed by in vivo pulse-
chase experiments in 4 days postfertilization (dpf) clcn7þ/þ
and clcn7del4/del4 transgenic Tg(cdh17::GFP) larvae after i.v.
injection of b-lactoglobulin-Cy5. The b-lactoglobulin-Cy5
signal was located at the subapical pole of pronephric PT cells
in both clcn7þ/þ and clcn7del4/del4 lines at 20 minutes
(Figure 1e, left panels) and up to 1 hour (middle panels) post-
injection. At 4 hours post-injection, the pronephric PT cells
of clcn7del4/del4 larvae accumulated considerable quantities of
fluorescent ligand, whereas it was completely degraded in
clcn7þ/þ larvae (clcn7þ/þ: 39  7 vs. clcn7del4/del4: 876  100,
P < 0.01; Figure 1e, right panels). In parallel, enlarged
electron-dense vesicles were observed by transmission elec-
tron microscopy in PT cells of clcn7-deficient larvae, as
compared to controls (Figure 1f). These results show that
specific defects in endocytosis (lrp2) and lysosomal processing
of the internalized ligand (clcn7), with corresponding ultra-
structural changes, can be detected in pronephric PT cells of
larvae with genetic defects along the endolysosomal pathway.
Generation and characterization of transgenic
Tg(lfabp::1/2vdbp-mCherry) line
Injection of fluorescent low-molecular-weight (LMW) tracer-
like b-lactoglobulin-Cy5 is labor-intensive and not easy to
accomplish for high-throughput functional assay. Both human
VDBP and zebrafish vdbp contain 2 homologous ALBUMIN
domains I and II (Supplementary Figure S3), which participate
in vitamin D sterol-binding.25 To create a novel, genetically
encoded endocytic LMW reporter protein (Figure 2a), we
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cloned the N-terminal 207aa-region containing the full
ALBUMIN domain I of zebrafish vdbp protein (referred to as
“
1/2vdbp”) and fused the latter with the open reading frame of
the acid-insensitive fluorophore mCherry (Figure 2b;
Supplementary Figure S4). As the promoter of the fabp10a gene
(coding for liver-type fatty acid binding protein 10a or lfabp) is
sufficient to modulate liver expression in zebrafish,26 the 3.1-kb
50 flanking sequence of the lfabp promoter was cloned to drive
the expression of 1/2vdbp-mCherry in liver (Figure 2b).
We next analyzed the synthesis and processing of
the endogenous 1/2vdbp-mCherry in stable transgenic
Tg(lfabp::1/2vdbp-mCherry) larvae. The expression of
1/2vdbp-
mCherry in transgenic zebrafish was confirmed by reverse-
transcription polymerase chain reaction (Figure 2c), western
blot (Figure 2d), and enzyme-linked immunosorbent assay
(ELISA; Figure 2e) in larval lysate and/or in isolated liver and
kidney tissue. Live microscopy validated signal for 1/2vdbp-
mCherry in the liver (Figure 2f and g), blood vessels—
especially the caudal vein (Figure 2f), and PT connected to
the glomerulus visualized in wt1b::GFP transgenic fish
(Figure 2h). Within pronephric PT cells, the uptaken 1/2vdbp-










































































































































































Figure 1 | Assessment of endolysosomal pathways in zebrafish models. (a) lrp2aþ/þ and lrp2adel8/del8 zebrafish embryos expressing
cdh17::GFP (green, pronephric tubule marker) were injected at 56-hour postfertilization (hpf) with b-lactoglobulin-Cy5. At 20 minutes after the
tracer injection, zebrafish larvae were imaged by a light sheet fluorescence microscope. Shown are representative micrographs demonstrating
the defective endocytosis of b-lactoglobulin-Cy5 in pronephric tubules of lrp2a zebrafish and quantifications of the Cy5 fluorescent signal;
n ¼ 6 (lrp2aþ/þ) and n ¼ 11 (lrp2adel8/del8). Bar ¼ 40 mm. (b) lrp2aþ/þ and lrp2adel8/del8 zebrafish embryos expressing cdh17::GFP (green,
pronephric tubule marker) were injected at 56 hpf with 10-kDa Alexa Fluor 647-Dextran. At 60 minutes after the tracer injection, the zebrafish
embryos were imaged. Representative micrographs demonstrate the defective endocytosis of Alexa Fluor 647-Dextran in pronephric
tubules of lrp2a zebrafish larvae and quantifications of the fluorescent signal; n ¼ 11 (lrp2aþ/þ) and n ¼ 9 (lrp2adel8/del8). Bar ¼ 40 mm. (c)
Representative electron micrographs showing loss of endocytic vesicles in proximal tubules (PTs) of lrp2a zebrafish larvae at 4 days
postfertilization (dpf) and quantifications of the number of endocytic vacuoles. Yellow squares contain images at a higher magnification. n¼ 6
(lrp2aþ/þ) and n ¼ 7 (lrp2adel8/del8). Bar ¼ 1 mm. (d) Whole-mount imaging of PT in lrp2a zebrafish larvae expressing PiT1::GFP-rab5aa (green,
endosomemarker) at 4 dpf. Shown are representative micrographs demonstrating loss of GFP fluorescence enrichment at the the apical side of
PT cells in lrp2a zebrafish and quantifications of GFP fluorescence intensity; n¼ 10 (lrp2aþ/þ) and n¼ 12 (lrp2adel8/del8). Bar¼ 40 mm. (Continued)
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as confirmed by confocal microscopy analysis of cryosections
(Figure 2i). These data demonstrate that 1/2vdbp-mCherry
produced in the liver of Tg(lfabp::1/2vdbp-mCherry) larvae is
filtered, reabsorbed, and processed in PT cells similar to
endogenous LMW proteins.
Analysis of the clearance of recombinant 6His-tagged
1/2vdbp-mCherry revealed that almost 70% of tracer was
removed from blood 30 minutes after injection, whereas the
reabsorbed fluorescent ligand was completely degraded in PT
cells 120 minutes post-injection (Supplementary Figure S5).
Of note, the reabsorption pattern of the endogenous
1/2vdbp-mCherry (Figure 2g) differs from the exogenous tracer
b-lactoglobulin-Cy5 (Figure 1e). This observation was
confirmed by injecting b-lactoglobulin-Cy5 in double trans-
genic Tg(lfabp::1/2vdbp-mCherry/cdh17::GFP) larvae: the
endogenous 1/2vdbp-mCherry was mainly uptaken by the early
PT segment, and the injected b-lactoglobulin-Cy5 was reab-
sorbed by the late portion of PT (Supplementary Figure S6).
PT dysfunction causes low-molecular-weight proteinuria in
transgenic reporter zebrafish
We next used genetic and toxic models to validate the
excretion of 1/2vdbp-mCherry in urine as an indicator of PT
dysfunction in the transgenic Tg(lfabp::1/2vdbp-mCherry)
larvae system (Figure 3a). Imaging of (megalin) lrp2a-defi-
cient Tg(lfabp::1/2vdbp-mCherry) larvae revealed a major
decrease in the 1/2vdbp-mCherry signal in the lrp2a
del8/del8
pronephros compared to lrp2aþ/þ larvae (lrp2aþ/þ: 12.1 
2.1 vs. lrp2adel8/del8: 3.4  0.6, P < 0.001; Figure 3b), con-























































































































Figure 1 | (Continued) (e) clcn7þ/þ and clcn7del4/del4 larvae expressing cdh17::GFP (green, pronephric tubule marker) were injected at 4 dpf
with b-lactoglobulin-Cy5. At the indicated times after the tracer injection, the zebrafish larvae were imaged. Representative micrographs
demonstrate the accumulation of the endocytosed ligand in the PT of clcn7 zebrafish and quantifications of the Cy5 fluorescent signal; n ¼ 10
(clcn7þ/þ) and n ¼ 7 (clcn7del4/del4) for the early time point; and n ¼ 6 (clcn7þ/þ) and n ¼ 5 (clcn7del4/del4) for the late time point. Bar ¼ 40 mm. (f)
Representative electron micrographs showing the accumulation of large electron-dense vesicles in PTs of clcn7 zebrafish at 4 dpf and
quantifications of the diameter of electron-dense vesicles; n ¼ 6 (clcn7þ/þ) and n ¼ 5 (clcn7del4/del4). Yellow boxes contain images at a higher
magnification. White asterisks indicate enlarged electron-dense vesicles. Bar ¼ 5 mm. Plotted data represent mean  SEM. Nonparametric
Mann-Whitney test, *P < 0.05, **P < 0.01, ***P < 0.001 relative to lrp2aþ/þ or clcn7þ/þ zebrafish. BB, brush border; N, nucleus; NS,
nonsignificant. To optimize viewing of this image, please see the online version of this article at www.kidney-international.org.
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paralleled by a 20-fold increase in urinary levels of 1/2vdbp-
mCherry measured by ELISA (lrp2aþ/þ: 2.5  0.3 pg/ml vs.
lrp2adel8/del8: 62.1  11.8 pg/ml, P < 0.001; Figure 3c).
Zebrafish larvae have been used previously to study the
nephrotoxicity of cisplatin and gentamycin, which induce
acute kidney injury in a dosage-dependent manner.10 We first
treated Tg(lfabp::1/2vdbp-mCherry) larvae with 1.5 mM
cisplatin. As expected, exposure to cisplatin induced a
defective development of swim bladder in 26.0% of treated
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Figure 2 | Generation and characterization of transgenic Tg(lfabp::1/2vdbp-mCherry) zebrafish reporter line. (a) Model depicting the
fate of 1/2vdbp-mCherry under normal conditions:
1/2vdbp-mCherry (w50 kDa) is (1) produced in liver, (2) secreted into the bloodstream,
(3) filtered by the glomerulus, (4) reabsorbed via receptor-mediated endocytosis by proximal tubule (PT) cells, and (5) processed within
endolysosomes. E, endosome; LE, late endosome; L, lysosome. (b) Vector construction of lfabp::1/2vdbp-mCherry: the N-terminal 207 amino
acids of zebrafish vdbp peptide is fused to mCherry and expressed under the control of the liver-specific lfabp promoter. Tol2-L and Tol2-R
motifs represent the Tol2 transposon left and right arms, which enable excision of the plasmid and integrate the construct into the
genome. lfabp, promoter of liver-type fatty acid binding protein; 1/2vdbp, N-terminal 207 amido acids of zebrafish vdbp peptide. (c) Transcript
levels of endogenous vdbp and transgene 1/2vdbp-mCherry were analyzed by reverse transcription polymerase chain reaction in liver
isolated from wild-type (WT) and transgenic (TG) adult zebrafish. Upper band: endogenous vdbp; lower band: 1/2vdbp-mCherry. (d) Western
blotting of mCherry protein in liver from WT and TG adult zebrafish. (e) Enzyme-linked immunosorbent assay and quantification of
1/2vdbp-mCherry in whole lysates derived from zebrafish larvae (lane 1), in urine derived from zebrafish larvae (lane 2), and in lysates obtained
from liver and kidney (lanes 3 and 4, respectively). LD, limit of detection. (f) Live imaging of transgenic larvae showing mCherry
fluorescence (red) in the liver (L), blood vessel, and PT of transgenic zebrafish larvae at 4 days postfertilization (dpf). The red signal in yolk sac
(YS) is from autofluorescence. White square indicates image at higher magnification. Arrows indicate the eye (E); PT; L; swim bladder (SB);
YS; and caudal vein (CV). Bar ¼ 500 mm. (g) Zebrafish larvae co-expressing lfabp::1/2vdbp-mCherry (red) and cdh17::GFP (green, pronephric
tubule marker) were imaged at 5 dpf by a light sheet fluorescence microscope. Representative micrographs showing the localization of
mCherry signal in L and PT of zebrafish larva. Bar ¼ 50 mm. (h) Zebrafish larvae co-expressing lfabp::1/2vdbp-mCherry (red) and wt1b::GFP (green,
glomerulus [G] and PT marker) were imaged at 5 dpf. 1/2vdbp-mCherry is uptaken by PTs connecting to the glomerulus. Bar ¼ 40 mm. (i)
Cryosections of fixed transgenic larvae co-expressing lfabp::1/2vdbp-mCherry and PiT1::ctns-EGFP (green, lysosomal marker) were imaged by
confocal microscopy. Shown are representative micrographs demonstrating the co-localization of 1/2vdbp-mCherry and ctns-EGFP in PT cells
and quantifications of mCherry and EGFP fluorescence intensities. The white line indicates the area where fluorescence intensities are
quantified for both mCherry and EGFP by using ImageJ (National Institutes of Health, Bethesda, MD). Yellow indicates co-localization. Bar ¼ 10
mm. To optimize viewing of this image, please see the online version of this article at www.kidney-international.org.
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Figure 3 | Failure of receptor-mediated endocytosis leads to urinary excretion of 1/2vdbp-mCherry. (a) Model depicting the fate of
1/2vdbp-mCherry in endocytosis-deficient conditions:
1/2vdbp-mCherry is not reabsorbed by proximal tubule (PT) cells and is ultimately excreted in
the urine. (b) lrp2aþ/þ and lrp2adel8/del8 zebrafish larvae co-expressing lfabp::1/2vdbp-mCherry and cdh17::GFP (green, pronephric tubule marker)
were imaged in vivo at 4 days postfertilization (dpf) by a light sheet fluorescence microscope. Shown are representative micrographs
demonstrating the defective endocytosis of 1/2vdbp-mCherry in lrp2a zebrafish and quantifications of
1/2vdbp-mCherry fluorescent signal in PT; n¼
16 (lrp2aþ/þ) and n ¼ 10 (lrp2adel8/del8). Bar ¼ 40 mm. L, liver. (c) Enzyme-linked immunosorbent assay (ELISA) and quantification of the urinary
1/2vdbp-mCherry showing loss of the endocytic ligand in urine collected from lrp2a zebrafish larvae; n¼ 12 (lrp2a
þ/þ) and n¼ 14 (lrp2adel8/del8). LD,
limit of detection. (d) Morphology of zebrafish embryos treated at 2 dpf with 1.5 mM cisplatin for 4 hours and semiquantitative scoring of
developmental defects of swim bladder at 4 dpf. n¼ 3 independent experiments. Bar¼ 1mm. (e) Zebrafish embryos co-expressing lfabp::1/2vdbp-
mCherry and cdh17::GFP (green, pronephric tubule marker) exposed to cisplatin were imaged in vivo at 5 dpf. Representative micrographs
demonstrate the defective endocytosis of 1/2vdbp-mCherry in cisplatin-treated transgenic larvae and quantifications of mCherry (continued)
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Three days after exposure, cisplatin-treated larvae showed a
significantly decreased mCherry fluorescent signal in PT cells
(untreated control: 8.6  0.9 vs. cisplatin-treated group: 5.4 
0.5, P < 0.01; Figure 3e), paralleled by a 20-fold increase in
urinary levels of 1/2vdbp-mCherry (untreated control: 2.6 
0.3 pg/ml vs. cisplatin-treated group: 50.7  11.9 pg/ml, P <
0.001; Figure 3f). As cisplatin is known to induce mito-
chondrial dysfunction,27 we analyzed global mitochondrial
respiration, which showed a significant decrease of oxygen
consumption rate in cisplatin-treated versus control larvae
(data not shown). Ultrastructural studies revealed a partial
loss of the brush border, loss of mitochondrial matrix, and
mitochondrial swelling in PT cells of cisplatin-treated larvae
(Figure 3g), as described previously.28,29
Aminoglycoside antibiotics such as gentamicin are inter-
nalized in PT cells via megalin, causing PT dysfunction and
structural damage.30,31 Gentamicin-induced acute tubular
damage can be prevented by taurine administration in rat
models.32 We exposed Tg(lfabp::1/2vdbp-mCherry) larvae to
gentamicin alone or co-injected with taurine in a 1:4 molar
ratio. Gentamicin-injected larvae showed mild (40%) and
severe (19%) edema associated with body curvature at 2 days
post-injection, compared to 22% (mild) and 11% (severe) of
gentamicin-taurine co-injected larvae (Figure 3h). Analysis of
urine collected at 2 days post-injection revealed high levels of
1/2vdbp-mCherry in gentamicin-injected larvae compared to
control larvae (gentamicin: 480  258 pg/ml vs. vehicle: 2.7 
0.4 pg/ml, P < 0.001). Co-injection of taurine with genta-
micin resulted in a significant attenuation of the urinary
excretion of 1/2vdbp-mCherry (105.7  71.7 pg/ml, P < 0.05
vs. gentamicin alone; Figure 3i). Ultrastructural analysis
showed the accumulation of lipid droplets in PT cells of
gentamicin-treated larvae, which was also partially rescued by
taurine co-injection (number of lipid droplets: vehicle, 0, vs.
gentamicin, 9.4  1.9, vs. gentamicin þ taurine, 5.2  1.4,
P < 0.001; Figure 3j). Western blotting data showed that the
production level of 1/2vdbp-mCherry was not affected by lrp2a
knockout or pharmacologic treatment with either cisplatin or
gentamicin (Supplementary Figure S7). Taken together, these
data demonstrate that genetic and toxic models of PT
dysfunction are associated with a significant loss of 1/2vdbp-
mCherry in the urine of the Tg(lfabp::1/2vdbp-mCherry)
larvae, which can be monitored by ELISA. The urinary levels
of 1/2vdbp-mCherry reflect the severity of the tubular damage
and the effect of protective strategies.
Transgenic zebrafish reporter for lysosomal storage diseases
Once internalized by receptor-mediated endocytosis in PT
cells, LMW proteins are delivered to early and late endo-
somes, and finally to lysosomes for enzymatic degradation in
an acidic environment. As the mCherry remains fluorescent
in an acidic environment, we hypothesized that 1/2vdbp-
mCherry could be useful for monitoring lysosomal dysfunc-
tion in PT cells (Figure 4a). Given that the clcn7del4/del4 larvae
are a model of lysosomal storage diseases (see above;
Figure 1e–g), we first analyzed the processing of 1/2vdbp-
mCherry in clcn7þ/þ and clcn7del4/del4 transgenic
Tg(lfabp::1/2vdbp-mCherry) larvae. As compared to clcn7
þ/þ
larvae, the accumulation of mCherry in PT cells was detected
in clcn7del4/del4 homozygous mutants, with both significantly
increased mCherry fluorescence intensity (clcn7þ/þ: 22  4.0
vs. clcn7del4/del4: 75.9  6.1, P < 0.001) and enlarged
mCherry-positive vesicles (clcn7þ/þ: 10.8  1.3 mm2 vs.
clcn7del4/del4: 29.5  2.0 mm2, P < 0.001; Figure 4b). Rein-
troduction of zebrafish clcn7 mRNA in homozygous mutant
larvae partially rescued both the fluorescence intensity
(clcn7del4/del4 þ clcn7 mRNA: 47.2  4.0, P < 0.01 vs. non-
injected control) and vesicle size (19.2  2.5 mm2, P < 0.05
vs. non-injected control), demonstrating that the renal
phenotype is specifically related to clcn7 gene deletion. The
accumulation of fluorescent ligand in the late-endosome/
lysosome in PT cells of clcn7del4/del4 larvae was confirmed by
correlative light and electron microscopy, where 1/2vdbp-
mCherry-positive endolysosomal compartments overlap with
the electron-dense vesicles in clcn7 mutant (Figure 4c).
We next exposed Tg(lfabp::1/2vdbp-mCherry) larvae to the
proton pump inhibitor bafilomycin A1 (BfnA1), which im-
pairs lysosomal acidification. After incubation with BfnA1 (20
nM for 16 hours), both fluorescence intensity (vehicle: 18.0 
3.1 vs. BfnA1: 36.9  2.9, P < 0.01) and total fluorescence
area (vehicle: 158  21 mm2 vs. Bfn A1: 333  37 mm2, P <
0.01) were significantly increased in PT cells compared to
vehicle-treated controls (Figure 4d). Western blotting data
showed that the production level of 1/2vdbp-mCherry was not
affected by clcn7 knockout or BfnA1 treatment
(Supplementary Figure S7D and E). These results indicate
=
Figure 3 | (continued) fluorescent signal; n ¼ 32 (control), n ¼ 47 (cisplatin-treated group). Bar ¼ 40 mm. (f) ELISA and quantifications of the
urinary 1/2vdbp-mCherry showing loss of the endocytic ligand in urine collected from cisplatin-treated transgenic zebrafish larvae; n ¼ 14
(control), n ¼ 31 (cisplatin-treated group). (g) Representative micrographs show loss of brush border (BB) and mitochondrial swelling in PT cells
of cisplatin-treated zebrafish larvae. Arrowhead indicates epithelial cells deprived of BB. Asterisks indicate mitochondrial swelling; n ¼ 7
(control), n ¼ 9 (cisplatin-treated group). Bars ¼ 5 mm in left panel and 2 mm in right panel. (h) Morphology of zebrafish larvae after i.v. injection
of 6 mg/ml gentamicin alone, or 6 mg/ml gentamicin þ 6.3 mg/ml taurine, or 0.9% NaCl vehicle solution into 2 dpf-transgenic embryos and
semiquantitative scoring of phenotypical change at 4 dpf; n ¼ 53 (gentamicin alone) and n ¼ 46 (gentamicin þ taurine). Bar ¼ 1 mm. (i) ELISA
and quantifications of the urinary 1/2vdbp-mCherry in transgenic zebrafish larvae treated with vehicle, gentamicin alone, and gentamicin þ
taurine injection; n ¼ 9 (vehicle), n ¼ 15 (gentamicin alone), and n ¼ 16 (gentamicin þ taurine). (j) Shown are representative micrographs
demonstrating lipid droplets in PTs from treated zebrafish larvae and quantifications of lipid droplets by transmission electron microscopy; n ¼
5 (vehicle), n ¼ 8 (gentamicin alone), and n ¼ 9 (gentamicin þ taurine). Bar ¼ 5 mm. Plotted data represent mean  SEM. Nonparametric
Mann-Whitney test, *P < 0.05, **P < 0.01, ***P < 0.001 relative to lrp2aþ/þ larvae or control. One-way analysis of variance followed by Kruskal-
Wallis test, *P < 0.05, **P < 0.01, ***P < 0.001 relative to gentamicin-treated larvae. To optimize viewing of this image, please see the online
version of this article at www.kidney-international.org.
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Figure 4 | Impaired lysosomal function results in defective processing of 1/2vdbp-mCherry. (a) Model showing the fate of
1/2vdbp-
mCherry in response to lysosomal dysfunctions induced by either genetic (clcn7 knockout) or pharmacologic (treatment with BfnA1) means.
(b) Transgenic clcn7þ/þ and clcn7del4/del4 larvae or clcn7del4/del4 injected with wild-type zebrafish clcn7 mRNA, which express lfabp::1/2vdbp-
mCherry in the liver, were imaged by a multiphoton fluorescence microscope at 5 days postfertilization (dpf). Shown are representative
micrographs and quantifications of mCherry fluorescence intensity and vesicle size, which demonstrate the accumulation of 1/2vdbp-mCherry
in clcn7 zebrafish, partially rescued by the re-introduction of wild-type clcn7 mRNA; n ¼ 8 zebrafish per group. Bar ¼ 30 mm (left panel) and 10
mm (middle panel). (c) Correlative light and electron microscopy (CLEM) in proximal tubules (PTs) of clcn7del4/del4 zebrafish larvae at 5 dpf
expressing lfabp::1/2vdbp-mCherry. Ultrathin sections of fixed zebrafish larvae were imaged with a widefield fluorescence microscope and
processed by super-resolution radial fluctuations analysis using ImageJ (National Institutes of Health, Bethesda, MD). The sections (continued)
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that the Tg(lfabp::1/2vdbp-mCherry) larvae system can also be
used to monitor the PT cell accumulation of 1/2vdbp-mCherry
in congenital (clcn7 knockout) or acquired (BfnA1) lysosomal
dysfunction.
DISCUSSION
In order to extend the use of zebrafish as a model organism
for kidney diseases, we have established a transgenic
Tg(lfabp::1/2vdbp-mCherry) zebrafish line expressing the low-
molecular-weight (LMW) 1/2vdbp-mCherry protein in the
liver. Unlike the GFP-tagged full-length vdbp, the endoge-
nously expressed 1/2vdbp-mCherry is secreted into the
bloodstream, filtered by the glomerulus, reabsorbed by PT
cells through receptor-mediated endocytosis, and processed
within endolysosomes. As it is pH-insensitive, the fluo-
rophore mCherry can be used to follow the fluorescent ligand
in acidic endolysosomal compartments. Studies using genetic
(knockout for lrp2a and clcn7) and pharmacologic (exposure
to gentamicin and cisplatin) models demonstrate that this
transgenic line is useful for monitoring LMW proteinuria and
lysosomal processing in PT cells, thus representing a powerful
new tool for drug screening and nephrotoxicity studies.
We first characterized the renal phenotypes of zebrafish
knockout lines for the endocytic receptor megalin (lrp2a) and
the lysosomal chloride channel ClC-7 (clcn7). Morphologic
and functional abnormalities displayed in the pronephros of 2
knockout lines mimic the phenotypes observed in knockout
mice, supporting their use to analyze the endolysosomal
pathway. Imaging of lrp2a-deficient transgenic
Tg(lfabp::1/2vdbp-mCherry) larvae revealed a major decrease in
the PT endocytic uptake of the 1/2vdbp-mCherry tracer,
resulting in the urinary excretion of 1/2vdbp-mCherry. These
features are similar to the defects encountered in megalin-
knockout mice,33 and patients with Donnai-Barrow
syndrome.34
Both receptor-mediated endocytosis and fluid-phase
endocytosis are impaired in the lrp2adel8/del8 mutant. Previ-
ous studies have demonstrated that the reabsorption of
dextran, a classical marker of fluid-phase endocytosis, is
impaired when receptor-mediated endocytosis is primarily
abolished in zebrafish larvae.9,11 This effect could be due to
the decreased number of endocytic vesicles formed in lrp2a-
deficient larvae, as most of the dextran is reabsorbed via such
endocytic vesicles, without binding to megalin receptor but
staying in the lumen fluid. Of note, the lrp2adel8/del8 mutant
developed enlarged eyes, a phenotype previously described in
the N-ethyl-N-nitrosurea-induced lrp2a mutant bugeye line.35
The lrp2a knockout zebrafish exhibit neither developmental
defects during larval stage nor a higher mortality in adults,
whereas megalin-deficient newborn mice die from perinatal
respiratory complications, with impaired pulmonary inflation
and alveolar expansion.36 Having gills, zebrafish do not
develop lungs and are thus not exposed to respiratory ab-
normalities related to megalin deficiency.
The Cl–/Hþ antiporter ClC-7 has been shown to be the
primary chloride permeation pathway in lysosomes and
important for lysosomal degradation activity,37 whereas ClC-
7 deficiency leads to lysosomal storage disease, osteropetrosis,
neurodegeneration, and retinal degeneration in mouse and
human.38–40 In particular, Clcn7-deficient mice show severe
dysmorphism and growth retardation and usually die before 7
weeks,39 whereas survival is not affected in clcn7 knockout
zebrafish. The lack of bone phenotype in the clcn7 knockout
zebrafish could be explained by species differences in bone
formation-resorption and/or the role of ClC-7 in extra-renal
tissues. For instance, ClC-7 requires its b-subunit Ostm1 to
support lysosomal function and bone resorption in mouse,41
and the stability of either protein is dependent on the co-
expression with its partner.42 Although zebrafish ClC-7 pro-
tein sequence shares relatively high similarity with mouse
ClC-7 (76% identical amino acids), the zebrafish ostm1
shares only 33% identical amino acids with mouse Ostm1.
Such differences in protein sequence could result in different
protein functions and different manifestations of the deletion
of ClC-7 across species.
The presence of LMW proteins in the urine is a consistent
hallmark of congenital and acquired forms of PT dysfunc-
tion.2 The value of the LMW proteinuria assay motivated us
to develop a transgenic zebrafish Tg(lfabp::1/2vdbp-mCherry)
reporter line using a shortened zebrafish vdbp peptide fused
to the acid-insensitive fluorophore mCherry. The transgenic
Tg(lfabp::1/2vdbp-mCherry) zebrafish synthesize
1/2vdbp-
mCherry in liver, from where it is secreted into the blood-
stream, freely filtered through the glomerulus, reabsorbed by
receptor-mediated endocytosis, and processed by lysosomes
in PT cells. The reabsorption and lysosomal processing of
1/2vdbp-mCherry by PT cells can be monitored by ELISA or
fluorescence imaging in vivo. To our knowledge, this is the
first transgenic reporter line for LMW proteinuria in zebra-
fish. A transgenic Tg(lfabp::vdbp-GFP) zebrafish line in which
=
Figure 4 | (continued) are further processed for ultrastructural analyses by using low-voltage scanning electron microscopy (LVSEM). Nuclei
are counterstained with 40,6-diamidino-2-phenylindole (DAPI; blue). Bar ¼ 2 mm. (d) Zebrafish larvae expressing lfabp::1/2vdbp-mCherry were
exposed to BfnA1 (20 nM; for 16 hours) and imaged at 5 dpf. Shown are representative micrographs and quantifications of fluorescence
intensity and total mCherry-positive area, which demonstrate the accumulation of 1/2vdbp-mCherry in BfnA1-treated zebrafish; n ¼ 11
zebrafish per group. Bar ¼ 30 mm (left panel) and 10 mm (middle panel). Plotted data represent mean  SEM. One-way analysis of variance
followed by Bonferroni post hoc test, *P < 0.05, **P < 0.01, ***P < 0.001 relative to clcn7del4/del4 zebrafish larvae in (b). Nonparametric Mann-
Whitney test, **P < 0.01 relative to vehicle-treated larvae in (d). ADP, adenosine diphosphate; ATP, adenosine triphosphate; BfnA1,
bafilomycin A1; DMSO, dimethylsulfoxide; EM, electron microscopy; IF, immunofluorescence; F, fiducial beads used for alignment of the IF
and EM images; L, lysosome; LE, late endosome; N, nucleus. To optimize viewing of this image, please see the online version of this article at
www.kidney-international.org.
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the 79.6-kD vdbp-GFP was synthesized in liver and secreted
into the bloodstream was previously reported.43 However, the
full-length vdbp fusion protein could not leak through the
zebrafish glomerular filtration barrier, so the vdbp-GFP may
be useful as only a tracer for glomerular permeability, but it is
not suitable for analyzing the function of PT cells. Interest-
ingly, the endogenously produced tracer 1/2vdbp-mCherry is
uptaken by the early PT segment, differing from the exoge-
nous tracer b-lactoglobulin-Cy5, which is mainly reabsorbed
by the more distal portions of the proximal tubule. This
observation could be due either to the chemical differences of
the tracers44 or to the saturation of reabsorption capacity of
the early portion of PT by the endogenous protein in physi-
ological conditions—so that any exogenous tracer would be
uptaken by the late portion of PT.
An important aspect of our study is that the urinary
excretion of 1/2vdbp-mCherry (i.e., LMW proteinuria) caused
by genetic (lrp2a deletion) or toxic (cisplatin or gentamicin)
injury can be assessed reliably by its detection in the pool
using an ELISA assay to quantify mCherry. The urinary
1/2vdbp-mCherry is detectable in cisplatin-treated larvae that
have not (yet) developed edema, showing that it is a sensitive
approach to monitoring tubular dysfunction.
Treatment with gentamicin is a well-established model of
acute kidney failure in rodent and zebrafish larvae.10,32 Our
data demonstrate that gentamicin treatment indeed induces
LMW proteinuria as monitored by elevated urinary 1/2vdbp-
mCherry levels in zebrafish larvae, whereas co-administration
of taurine partially rescues the LMW proteinuria and the
accumulation of lipid droplets. Thus, the urinary levels of
1/2vdbp-mCherry in this reporter line reflect the severity of
the tubular damage and the effect of protective strategies. It
has been suggested that taurine acts through several mecha-
nisms to limit the degree of lipid peroxidation and membrane
damage and increases overall mitochondrial function.45 The
mechanism underlying the rescue by taurine requires further
investigation. The assessment of urinary 1/2vdbp-mCherry in
E3 zebrafish larval medium is a simple and non-invasive
technique, useful for monitoring receptor-mediated
endocytosis.
Besides monitoring LMW proteinuria, we also evaluated
the potential use of the transgenic Tg(lfabp::1/2vdbp-mCherry)
zebrafish line to analyze lysosomal storage diseases, which are
characterized by the intra-lysosomal accumulation of mole-
cules.46 Lysosomes are catabolic centers that break down and
recycle a series of substrates through the concerted action of
hydrolases, acidic machinery, and membrane proteins/trans-
porters. Accumulation of undigested material is commonly
seen in kidney tubular epithelial cells in lysosomal storage
diseases, such as in mice deficient in ClC-740 or cystinosin.47
An important point to note is that mCherry can be
followed by imaging once it reaches the acidic lysosomal
compartment—as shown by its co-localization with lyso-
somal marker ctns-EGFP in PT epithelial cells. In transgenic
Tg(lfabp::1/2vdbp-mCherry) zebrafish, the inhibition of lyso-
somal function by treatment with BfnA1 or by the deletion of
clcn7 induces the accumulation of 1/2vdbp-mCherry in pro-
nephric PT cells. These data demonstrate that the 1/2vdbp-
mCherry is degraded once reabsorbed by PT cells in physi-
ological conditions, as it does the native VDBP.19 They also
substantiate the importance of lysosomal acidification and
chloride homeostasis for the lysosomal processing of endo-
cytosed ligands. A combination of the Tg(lfabp::1/2vdbp-
mCherry) zebrafish reporter line with models of glomerular
diseases will be useful for analyzing the effects of protein
overloading on PT function.
In this study, we applied for the first time a correlative light
and electron microscopy (CLEM) method for imaging the
ultrastructure of zebrafish pronephros by scanning electron
microscopy and its correlation with super-resolution light
microscopy. This method has been used to analyze synapses
in mouse brain tissue and mitochondrial cristae in zebrafish
retina.48 Our data show that the use of correlative light and
electron microscopy, combined with super-resolution radial
fluctuations analysis,49 is a reliable and precise method for
monitoring the structure and morphology of lysosomes, and
by extension, autophagic vesicles in zebrafish pronephric PT
cells.
In summary, the generation and proof-of-principle char-
acterization of the transgenic Tg(lfabp::1/2vdbp-mCherry)
zebrafish reporter line opens perspectives for the study of
various aspects of congenital and acquired forms of PT
dysfunction and substantiates the use of zebrafish for drug
screening and nephrotoxicity studies.
METHODS
Zebrafish maintenance and chemical treatment
Zebrafish (Danio rerio) were kept at a day/night cycle of 14/10 hours
at 28 C. Embryos were obtained through natural spawning in the
Fish Facility of the University of Zurich (Zurich, Switzerland) and
raised in E3 medium containing 0.01% methylene blue. For cisplatin
treatment, 2-days postfertilization (dpf) zebrafish embryos were
treated with E3 medium containing 1.5 mM cisplatin (Sigma,
C2210000, Buchs, Switzerland) for 4 hours and reincubated with
fresh E3 medium until phenotypic analysis. The number of zebrafish
larvae showing defective development of swim bladder was counted
manually under a stereo microscope. For gentamicin treatment, 2-
dpf zebrafish embryos were injected with 1 nl of 6 mg/ml genta-
micin /0.9% NaCl solution (Sigma, G1264) alone or co-injected with
6.3 mg/ml taurine (Sigma, T0625) into the common cardinal vein
after anesthesia with 0.2 mg/ml Ethyl 3-aminobenzoate meth-
anesulfonate salt (Sigma, E10521). Embryos were immediately
reincubated in fresh medium until phenotypical analysis. The
morphology of zebrafish larvae was analyzed at 4 dpf under a stereo
microscope and classified as follows: stage I: no morphologic change;
stage II: mild edema; and stage III: severe edema.50 Overnight urine
excreted in E3 medium was collected individually after 2 days
(gentamicin) or 3 days (cisplatin) of treatment. Embryos were
treated with 0.003% N-Phenylthiourea (Sigma, 222909) prior to
in vivo larval imaging. Stock solution of BfnA1 (Sigma, B1793) was
prepared in dimethylsulfoxide, and zebrafish larvae were treated with
E3 medium containing 20 nM BfnA1 for 16 hours at 28 C. The
experiments performed on animals were approved by the local legal
authority (Veterinary Office, Canton of Zurich, Switzerland).
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Generation of lrp2a and clcn7 knockout zebrafish by TALEN
technology
lrp2a- and clcn7-specific TALENs were constructed according to
Golden Gate TALEN assembly protocol and using the Golden Gate
TALEN and TAL Effector Kit 2.0 (Addgene Kit #1000000024,
Watertown, MA). CIscript-Goldy TALEN was a gift from Daniel
Carlson & Stephen Ekker (Addgene plasmid #38142), and TALENs
were designed with the TAL Effector Nucleotide Targeter 2.0 soft-
ware available on the Cornell University website. The lrp2a-TALENs
target exon 75 of the zebrafish lrp2a gene: lrp2a-TALEN-Left:
CCCTTTAATGTTGTTTGT and lrp2a-TALEN-Right: TACTGT
TAGCAGTGGTGATT. The clcn7-TALENs target exon 7 of the
zebrafish clcn7 gene: clcn7-TALEN-Left: GATTATTTATTTTTTCACA
and clcn7-TALEN-Right: AAGTGGAATCCCTCAAATAAA. The
spacer of 2 TALEN target sites for both genes is 15 nucleotides,
containing the AciI (for lrp2a) and PstI (for clcn7) restriction site
used for mutant screening. The TALEN expression plasmids were
linearized with BamHI and then used for in vitro transcription
(mMESSAGE mMACHINE T3 kit, Ambion, Austin, TX). Approxi-
mately 1 nL of TALEN mRNAs (400 ng/ml) was injected into one-cell
stage zebrafish embryos. After 24 hours, genomic DNAwas extracted
from injected embryos with normal appearance. Targeted genomic
loci were amplified using primers designed to anneal approximately
430 base pairs (bp) for lrp2a and 240 bps for clcn7, and a mutant
allele was detected by enzymatic digestion of the polymerase chain
reaction product. The TALENs-injected adulthood (F0) zebrafish
were outcrossed with wild-type zebrafish, and embryos were then
raised to adulthood (F1) for screening of heterozygous carriers.
Homozygous mutants (F2) were generated from incrossing of het-
erozygous fish for phenotypic analysis. The structure of wild-type
and mutated lrp2a/megalin and chloride channel 7 proteins is pre-
dicted with the open-source tool Protter (ETH Zurich, Zurich,
Switzerland).
For mRNA rescue, zebrafish clcn7 cDNA was synthetized by
reverse transcription of total RNA extracted from wild-type zebrafish
kidney using iScript cDNA Synthesis Kit (BioRad, Hercules, CA) and
primers clcn7-Fw: 50-TATGGCCAACATCACGAAGAA-30, clcn7-Rev:
50-ATCATGTCTGTGCCAGCTGAA-30. The clcn7 cDNA was cloned
into the pDrive TOPO cloning vector (Qiagen, Basel, Switzerland).
The plasmid pDrive-zf-clcn7 was linearized with BamHI and then
used for in vitro transcription (mMESSAGE mMACHINE SP6 kit,
Ambion), followed by Poly(A) tailing by E-PAP enzyme. Approxi-
mately 1 nL of clcn7 mRNAs (600 ng/ml) was injected into the one-
cell stage of transgenic clcn7 knockout embryos, and the phenotype
was analyzed at 5 dpf.
Generation of transgenic line with tissue-specific expression
of reporter protein
The promoters of the zebrafish fabp10a (fatty acid binding protein
10a, liver type-fabp, or lfabp) and slc20a1a (PiT1, phosphate trans-
porter 1) genes were amplified from zebrafish genomic DNA by
polymerase chain reaction (Platinum Taq DNA Polymerase High
Fidelity Kit, Invitrogen, Basel, Switzerland) and cloned with pENTR
50-TOPO TA Cloning Kit (Invitrogen). EGFP-RAB7A was a gift from
Gia Voeltz (Addgene plasmid #61803). Zebrafish ctns cDNA was
synthetized by reverse transcription of total RNA extracted from
zebrafish embryo using an iScript cDNA Synthesis Kit (BioRad).
Zebrafish rab5aa cDNA was cloned from wild-type zebrafish larvae
and fused with GFP coding sequence using pCS-GFP vector. The
coding sequence of N-terminal 207 aa of the zebrafish gc gene
(vitamin D binding protein, vdbp) was cloned from isolated
zebrafish liver and fused with mCherry open reading frame using
pCS2-mCherry vector. Middle-entry clones pED-1/2vdbp-mCherry,
pED-GFP-rab5aa, pED-EGFP-RAB7A, and pED-ctns were prepared
using pENTR/D-TOPO Cloning Kit (Invitrogen). The construction
of plasmids lfabp::1/2vdbp-mCherry, PiT1::GFP-rab5aa, PiT1::EGFP-
RAB7A, and PiT1::ctns-EGFP were realized after LR Reaction
(Gateway LR Clonase II Enzyme Mix, Invitrogen; the LR Reaction is
a recombination reaction between attL and attR sites, which use
the LR clonase for vector construction) using destination vector
pDestTol2CG2 (Tol2 kit v1.2) with cmlc2::EGFP transgenesis marker,
homemade 50-entry clones and middle-entry clones, as well as 30-
entry clones p3E-EGFPpA and p3E-polyA. Plasmid DNA was co-
injected with Tol2 transposase mRNA into zebrafish embryo at the
one-cell stage to generate stable transgenic lines. Primers used to
clone promoters and cDNA are: lfabp-Fw: 50-AAATGCAAATTCTGA
GCAAATGAC-30; lfabp-Rev: 50-GCTTTCTGGAGAAGCTCAACA-30
(3527 bp); PiT1-Fw: 50-CAAAGTGCCAGTAGC-CATTGA-30; and
PiT1-Rev: 50-TGAATGTCTTCTGCTGGGTTG-30 (3496 bp). rab5aa-
Fw: 50-AAATCAGTTCAAGCAACCTGTC-30; rab5aa-Rev: 50-GGTA
ACAGAGTTTGGTGAGGG-30 (793 bp); ctns-Fw: 50-CCTTCCGCGT
ATGGAGTAGC-30; ctns-Rev: 50-CCCGGTCAGGTTTTCACACT-30
(1240 bp); vdbp-Fw (with BamHI site): 50-TCTAACTCATCTTGA
AATTATAACCAGTGGATCCTAAGAAATGATGAATGCATCTTTAAT
TTTAATTTATG-30; and vdbp-Rev (with BamHI site): 50-CTCAGA
AAAATGTTGGATCCTCTCATCTGGATTCTCTCTTGGAAAAAAC
AAGA-30.
Double transgenic zebrafish larvae were produced after incross of
transgenic Tg(lfabp::1/2vdbp-mCherry) zebrafish with transgenic
Tg(cdh17::GFP), Tg(wt1b::GFP), or Tg(PiT1::ctns-EGFP).
Production and purification of recombinant 1/2vdbp-mCherry
for clearance studies
Recombinant 6xHis-tagged 1/2vdbp-mCherry and (His)6-fusion
proteins were produced using the ExpiCHO Expression System
(Thermo Fisher Scientific, Basel, Switzerland). The expression vector
pCMV-1/2vdbp-mCherry-6His was transiently transfected into
ExpiCHO-S cell in serum-free ExpiCHO Expression Medium using
ExpiFectamine CHO Reagent. At 20 hours after transfection, Expi-
Fectamine CHO Enhancer and ExpiCHO Feed were added into the
medium, which was collected for purification 3 days after trans-
fection. The medium, supplemented with ethylenediamine tetra-
acetic acid–free Protease Inhibitor Cocktail (cOmplete; Roche,
Mannheim, Germany) and 1 mM phenylmethylsulfonyl fluoride was
concentrated and cleaned up with Amicon Ultra-15 filter unit (PLTK
Ultracel-PL Membran, 30 kDa; Merck Millipore, Cork, Ireland) and
binding buffer (20 mM Tris pH 8.0, 500 mM NaCl, 5 mM imidazole,
protease inhibitor , and phenylmethylsulfonyl fluoride). After ul-
tracentrifugation (170,000 g for 1hour at 4 C), the supernatant was
purified by Ni2þ-affinity chromatography using HiTrap Chelating
High Performance column (GE17-0408-01 SIGMA; GE Healthcare,
Uppsala, Sweden) and Fast Protein Liquid Chromatography (FPLC,
Bio-Rad). The recombinant 1/2vdbp-mCherry-6His protein was
rescued in elution buffer (20 mM tris(hydroxymethyl)-
aminomethane, pH 8.0, 500 mM NaCl, 500 mM imidazole),
filtered and cleaned up 3x with 30-kDa-filter unit and phosphate
buffered saline (PBS) solution to remove imidazole, followed by 1x
filtration with a 50-kDa-filter unit and concentration determination
by using an ELISA mCherry kit.
The clearance rate of 1/2vdbp-mCherry was analyzed following i.v.
injection of the purified recombinant protein (single bolus injection
of 1 nl of 0.3 mg/ml 1/2vdbp-mCherry-6His) in transgenic larvae
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expressing EGFP-RAB7A. The fluorescence signal was analyzed in
the dorsal aorta at 5, 15, 30, and 60 minutes after tracer injection,
and in the proximal tubule at 15 and 120 minutes post-injection.
Endocytic activity assay
Bovine b-lactoglobulin (Mr 18,400, Sigma) was labeled and
purified with Cy5 TM2 Ab labelling kit (Amersham BioSciences,
PA35000, Little Chalfont Buckinghamshire, UK) according to
manufacturer instructions. b-lactoglobulin-Cy5 injection solution
was prepared at 5 mg/mL final concentration. Transgenic
Tg(cdh17::GFP) larvae expressing GFP in pronephric epithelial
cells (Dr. Frank Bos, Utrecht, The Netherlands) were anaesthetized
with 0.2 mg/mL tricaine solution in egg water, prior to injection
of b-lactoglobulin-Cy5 or 10-kDa dextran-Alexa Fluor 647 (Invi-
trogen, D22914) into the common cardinal vein. Tracer injection
into larvae blood was confirmed by immediate observation of
positive fluorescent vessels. Larvae were reincubated in fresh E3
medium for 20 minutes, 1 hours, or 4 hours, followed by over-
night fixation with 2% paraformaldehyde/PBS containing 0.1%
tween 20.
Fluorescence microscopy
A lightsheet fluorescence microscope (ZEISS Lightsheet Z.1, Carl
Zeiss Microscopy, Jena, Germany) was used to visualize the
expression of transgenic reporter lines in vivo or in fixed larvae
after tracer injection by using 20/1.0 NA water immersion
objective (W Plan APO, Zeiss). The whole-larva imaging was fol-
lowed by genotype assessment before data analysis was performed.
Images were processed with Imaris (Bitplane, Zurich, Switherland)
to generate a maximum-intensity projection of Z-stack, which was
used for the quantification of the fluorescence intensity with ImageJ
(National Institutes of Health, Bethesda, MD). Quantitative analysis
of fluorescent signals was performed with one whole pronephric
tubule for each larva using the same setting parameters. A multi-
photon fluorescence microscope (Leica TCS SP8 Upright MP FLIM;
Leica Microsystems, Heerbrugg, Switzerland) was used to acquire
high-resolution images to ananlyze the fluorescent vesicles in
proximal tubules by using 25/1.0 NA water immersion objective
(HC IRAPO L, Leica). The excitation wavelength was 1100 nm
(tunable laser) for imaging of mCherry alone, and a 925-nm
tunable laser and a 1041-nm fixed-wavelength laser were used for
dual-color imaging of EGFP and mCherry. The acquired data were
processed by Huygens software (Scientific Volume Imaging, Hil-
versum, The Netherlands) for deconvolution, followed by seg-
mentation using ilastik software (EMBL, Heidelberg, Germany) and
quantification of individual vesicle size or total vesicle area for each
stack using ImageJ. For co-localization analysis, fixed transgenic
larvae were infiltrated with 30% sucrose at 4 C overnight,
mounted in Tissue-Tek O.C.T. Compound (TissueTek, Sakura
Finetek, Alphen aan den Rijn, The Netherlands), and frozen at
80 C. 10-mm cryosections were prepared and analyzed by a Leica
SP8 upright confocal microscope with a 40 oil immersion
objective (HCX PL APO, Leica Microsystems, Wetzlar, Germany).
A single Z-stack was used for quantification of GFP and mCherry
fluorescence signal by ImageJ.
Transmission electron microscopy
After tail cutting, zebrafish larvae were fixed in 2.5% glutaraldehyde
and 1.6% paraformaldehyde in 0.1 M cacodylate buffer, pH 7.3,
overnight. After rinsing in 0.1 M cacodylate buffer, larvae were then
post-fixed in 1% osmium tetroxide in cacodylate buffer for 40
minutes at room temperature and stained in 1% aqueous uranyl
acetate for 1 hour at room temperature. After dehydration through a
graded series of ethanol, samples were infiltrated and embedded in
Epon812 (Sigma, Buchs, Switzerland) at 60 C for 28 hours. 350-nm
semi-thin sections were prepared on a Leica EM FCS ultra-
microtome (Leica Microsystems) and stained by Toluidine blue so-
lution. 60-nm ultra-thin sections were collected onto formvar-coated
copper grids, stained with lead phosphate dilution in water, and
analyzed on an electron microscope (Philips CM100, Philips Elec-
tron Optics, Eindhoven, The Netherlands) at 80kV. Image analysis
was made using ImageJ. The vesicle number was counted manually,
and the vesicle diameter is expressed as the average of membrane-to-
membrane diameter based on the x and y axes.
Correlative light and electron microscopy
After removing the head and tail, zebrafish larvae were fixed in
0.05% glutaraldehyde and 4% formaldehyde in 0.1 M cacodylate
buffer at 4 C overnight. To achieve better cutting stability, the tissue
pieces were embedded in 12% gelatin (local food brand, Extra Gold,
Dr. Oetker) in 0.1 M phosphate buffer, pH 7.4, at 40 C. After
hardening, 1--1 mm pieces were cut out on ice and then incubated
in 2.3 M sucrose at 4 C. After 2 washes in 2.3 M sucrose, the tissue/
gelatin pieces were stored at –20 C or further processed in fresh 2.3
M sucrose. Tissue/gelatin pieces were mounted on a cryo pin (Leica
Microsystems) and cryosectioned with a cryosectioning device (UC6,
Leica Microsystems). 110-nm Tokuyasu cryosections were collected on
silicon wafers (7  7 mm, Si-Mat Silicon Materials, Kaufering,
Germany). Prior to sample collection, wafers were glow-discharged,
and fluorescent beads of 170 nm (PS-SpeckTM, Thermo Fisher)
were added as fiducial markers. After collection, samples were
washed twice with PBS and stained with 40, 6-diamidino-2-
phenylindole for 30 seconds. The sections on wafer were then
incubated in 87% glycerin (Sigma)/PBS 1:1 solution for 2  10
seconds and then transferred with the sections facing down to a
glass-bottom petri dish (Ibidi, Gräfelfing, Germany) and imaged
with a Widefield fluorescence microscope (Leica Microsystems TIRF
- Leica SR GSD 3D) with a x160/1.43 NA oil immersion objective
(HCX PL APO, Leica Microsystems) acquiring 1000 images per
channel for the super-resolution radial fluctuations analysis. Before
ultrastructural analysis, the ultrathin sections were washed with PBS,
post-fixed with 0.1% glutaraldehyde in PBS for 5 minutes, and
incubated with 2% methylcellulose in water at 0 C (2  5 minutes).
The wafers were then centrifuged at 14,100  g for 90 seconds,
heated at 40 C for 10 minutes, mounted on a scanning electron
microscopy aluminium stub with conducting carbon cement
(Conductive Carbon, Plano, TX), and imaged in a scanning electron
microscope (Zeiss Auriga 40 CrossBeam, Carl Zeiss Microscopy)
using an acceleration voltage of 1.5 keV.48 Fluorescence images were
processed with the plugin Super-Resolution Radial Fluctuations49
within the open-source platform Fiji. Fluorescent beads registered
in the light and electron microscopy images were used for the
alignment of the images with TrakEM2 (Zurich, Switzerland).51
Reverse-transcription polymerase chain reaction
Total RNA was extracted from liver tissue isolated from adult
zebrafish using TRIzol Reagent (Invitrogen) and T10 Basic Ultra-
Turrax Disperser (IKA, Staufen, Germany). DNAse I treatment was
performed to eliminate genomic DNA contamination. One micro-
gram of RNA was converted into cDNA using an iScript cDNA
Synthesis Kit (Bio-Rad). The cDNA of vdbp and 1/2vdbp-mCherry
was detected by polymerase chain reaction using Phusion
Z Chen et al.: Transgenic fish for low-molecular-weight proteinuria bas i c re sea r ch
Kidney International (2020) 97, 1150–1163 1161
High-Fidelity PCR Master Mix (New England Biolabs, Hitchin, UK)
and specific primers: vdbp-cDNA-Fw: 50-ATGAATGCATCTT-
TAATTTTAATTTATGCTTTAATAGT-30 (containing the start codon
of vdbp cDNA) and vdbp-cDNA-Rev: 50-TTCAGGCGATCTCTT-
CATCCA-30 (located on the 30 Untranslated Transcribed Region of
vdbp cDNA; for vdbp cDNA, 1459 bp), and vdbp-mCherry-Fw: 50-
GCATCCAGGCATTGAGCAG-30 (located on the N-terminus of
vdbp cDNA) and vdbp-mCherry-Rev: 50-TTACTTGTACAGCTC
GTCCATGC-30 (containing stop codon of mCherry open reading
frame; for 1/2vdbp-mCherry, 1030 bp).
Western blotting
Zebrafish larval or liver tissue was homogenized in RIPA buffer
(Sigma, R0278) by sonication, and protein concentration was
determined using Pierce BCA Protein Assay Kit (ThermoFisher,
23225). Samples were mixed with Laemmli sample buffer and
separated by sodium dodecylsulfate–odecylsulfatesulfateparated by
ted under reducing conditions. After blotting onto polyvinylidene
diflouride membrane and blocking with 5% nonfat milk (Bio-Rad,
1706404) diluted in PBS, the membranes were incubated overnight
at 4 C with primary antibody against mCherry (Abcam, ab167453;
Cambridge, UK), b-actin (Sigma, A5441), or glyceraldehyde-3-
phosphate dehydrogenase (Cell Signaling, 14C10; Leiden, The
Netherlands). After being washed and incubated with peroxidase-
labeled secondary antibody (Dako, Glostrup, Denmark), the mem-
branes were visualized with ChemiDoc Touch Imaging System
(Bio-Rad).
Urine collection and ELISA mCherry
Zebrafish larvae were placed in a 96-well microplate with one larvae/
100 ml E3 medium/well and kept at 28 C for 16 hours, followed by
urine collection for ELISA assays. Liver and kidney tissues were
extracted using 1x Cell Extraction Buffer PTR and diluted with
Sample Diluent NS from the mCherry ELISA kit (Abcam,
ab221829). 1/2vdbp-mCherry was assayed according to
manufacturer-recommended protocol, which is briefly as follows: 50
ml E3 medium containing urine was distributed to a 96-well
microplate pre-coated with anti-mCherry antibody. A 50-ml
mixture of capture antibody and detector antibody was added to
each well and incubated at 37 C for 1 hour. The wells were rinsed 3
times with 1 Wash Buffer PT and incubated with 100 ml of TMB
Substrate at room temperature for 10 minutes. The reaction was
stopped by adding 100 ml of stop solution, followed by reading the
absorbance of each well at 450 nm.
Statistical analysis
The software Prism 5 (GraphPad Software, San Diego, CA) was used
for all statistical analyses. The D’Agostino-Pearson normality test was
applied to all data sets. For experiments with more than 2 condi-
tions, differences between experimental groups were evaluated using
one-way analysis of variance followed by Bonferroni or Kruskal-
Wallis post hoc tests. When only 2 groups were compared, either
an unpaired 2-tailed t-test or a Mann-Whitney test was used.
For experiments with lrp2a and clcn7 lines, larvae generated from
crossing heterozygous lines were used. Whole-mount imaging was
done in a blinded manner, before genotype determination. Thus, the
exact sample size in each experiment was variable. None of the
samples was excluded from the experiment. Zebrafish embryos were
randomly selected for the chemical-treatment group or control
group. Statistical significance was set at P < 0.05.
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